User 16, a 68-year-old woman bedridden with L5 spinal stenosis and scoliosis, used an unusually high BPC-157 dose of 2.5mg daily alongside 200mcg TB-500 daily, transitioning the TB-500 to every third day after two weeks
Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
Not vague disclaimers, not fear, just facts
Vial Duration At 1 mL weekly 10 weeks per vial At 1 mL twice weekly 5 weeks per vial At 0.5 mL weekly 20 weeks per vial Final Simplified Protocol Draw: 1 mL (100 units) = 1 mg B12 + Lipo-C blend Frequency: 12x per week Cycle: Ongoing for energy, fat metabolism, and wellness research Vial Supply: 520 weeks depending on frequency & dose
Manufacturing complexity Peptide synthesis requires specialized equipment and expertise
The peptide stacking guide and BPC-157 and TB-500 stacking guide provide frameworks for combining peptides safely
.png)
